United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - technetium tc-99m sestamibi (unii: 971z4w1s09) (technetium tc-99m sestamibi - unii:971z4w1s09) - technetium tc-99m sestamibi 1 mg in 10 ml - myocardial imaging: technetium tc 99m sestamibi injection is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions. technetium tc 99m sestamibi evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques (e.g., exercise or pharmacologic stress in accordance with the pharmacologic stress agent’s labeling). it is usually not possible to determine the age of a myocardial infarction or to differentiate a recent myocardial infarction from ischemia. breast imaging: technetium tc 99m sestamibi is indicated for planar imaging as a second line diagnostic drug after mammography to assist in the evaluation of breast lesions in patients with an abnormal mammogram or a palpable breast mass. technetium tc 99m sestamibi is not indicated for breast cancer scree

United States - English - NLM (National Library of Medicine)

lantheus medical imaging, inc. - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate (unii: n6ou7hj70p) (tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate - unii:n6ou7hj70p) - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate 1 mg in 1 ml - myocardial imaging: technetium tc99m sestamibi is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions. technetium tc99m sestamibi evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques (e.g., exercise or pharmacologic stress in accordance with the pharmacologic stress agent's labeling). it is usually not possible to determine the age of a myocardial infarction or to differentiate a recent myocardial infarction from ischemia. breast imaging: technetium tc99m sestamibi is indicated for planar imaging as a second line diagnostic drug after mammography to assist in the evaluation of breast lesions in patients with an abnormal mammogram or a palpable breast mass. technetium tc99m sestamibi is not indicated for breast cancer screening, to co

United States - English - NLM (National Library of Medicine)

cardinal health 414, llc - technetium tc-99m sestamibi (unii: 971z4w1s09) (technetium tc-99m sestamibi - unii:971z4w1s09) - technetium tc-99m sestamibi 1 mg in 5 ml - myocardial imaging: technetium tc 99m sestamibi injection is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions. technetium tc 99m sestamibi evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques (e.g., exercise or pharmacologic stress in accordance with the pharmacologic stress agent’s labeling). it is usually not possible to determine the age of a myocardial infarction or to differentiate a recent myocardial infarction from ischemia. breast imaging: technetium tc 99m sestamibi is indicated for planar imaging as a second line diagnostic drug after mammography to assist in the evaluation of breast lesions in patients with an abnormal mammogram or a palpable breast mass. technetium tc 99m sestamibi is not indicated for breast cancer scree

United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - technetium tc-99m medronate (unii: x89xv46r07) (technetium tc-99m medronate - unii:x89xv46r07) - medronic acid 20 mg in 10 ml - technetium tc 99m medronate injection may be used as a bone imaging agent to delineate areas of altered osteogenesis. none known.

United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - mebrofenin (unii: 7pv0b6ed98) (mebrofenin - unii:7pv0b6ed98) - mebrofenin 45 mg in 10 ml - technetium tc 99m mebrofenin is indicated as a hepatobiliary imaging agent. hypersensitivity to this compound.

Canada - English - Health Canada

edmonton radiopharmaceutical centre (alberta health services) - medronic acid - kit - 10mg - medronic acid 10mg - roentgenography

Canada - English - Health Canada

edmonton radiopharmaceutical centre (alberta health services) - medronic acid - kit - 20mg - medronic acid 20mg - roentgenography

United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - betiatide (unii: 9nv2sr34p8) (betiatide - unii:9nv2sr34p8) - technetium tc 99m mertiatide is a renal imaging agent for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi in adults and pediatric patients. (see pediatric use.) it is a diagnostic aid in providing renal function, split function, renal angiograms, and renogram curves for whole kidney and renal cortex. none known.

United States - English - NLM (National Library of Medicine)

cardinal health 414, llc - technetium tc-99m medronate (unii: x89xv46r07) (technetium tc-99m medronate - unii:x89xv46r07) - technetium tc 99m medronate may be used as a bone imaging agent to delineate areas of altered osteogenesis. none known.

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

arabian ethicals co. jordan - kit (15 ml dropper bottle + aspirator) - drops - combination - ear nose , oropharynx-nose